Showing results (131-140 of 201) with videos related to
Sort By:
Pageof 21
British Journal of Obstetrics and Gynaecology|November 1, 1984
Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administrationU B Ottoson, K Carlstrom, J E Damber, et al.The Prostate|January 1, 1995
Effects of estrogens and progestogens on the membrane permeability and growth of human prostatic carcinoma cells (PC-3) in vitroA Widmark, K Grankvist, A Bergh, et al.The Prostate|January 1, 1992
Effects of 6-methylene progesterone on growth, morphology, and blood flow of the Dunning R3327 prostatic adenocarcinomaJ E Damber, A Bergh, L Daehlin, et al.Journal of Reproduction and Fertility|May 1, 1985
Altered concentrations of gonadotrophin, prolactin and GnRH receptors, and endogenous steroids in the abdominal testes of adult unilaterally cryptorchid ratsA Bergh, H Nikula, J E Damber, et al.Urological Research|January 1, 1997
Decrement of blood flow precedes the involution of the ventral prostate in the rat after castrationE Lekås, M Johansson, A Widmark, et al.British Journal of Urology|February 1, 1984
Sexual function in prostatic cancer patients treated with radiotherapy, orchiectomy or oestrogensB Bergman, J E Damber, B Littbrand, et al.BJU International|July 12, 2001
Castration-induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancerS Häggström, P Stattin, P Wikström, et al.The Prostate|June 9, 2001
Gonadotropin-releasing hormone receptor expression in the human prostateTieva A, P Stattin, P Wikström, et al.Cancer Epidemiology|August 13, 2010
A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancerJ Hammarsten, J-E Damber, R Peeker, et al.European Urology|January 1, 1996
p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancerP Stattin, A Bergh, L Karlberg, et al.Pageof 21